Takeda Pharmaceutical Company Limited (TAK)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$16.37
+0.03%
Mkt Cap $57.09B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Jan 29, 2026 | $7.54B | $7.73B | +2.48% | $0.55 | $0.48 | -12.73% | — | — |
| Q4 2025 Oct 30, 2025 | $7.48B | $7.42B | -0.85% | $0.44 | $0.44 | +0.00% | — | — |
| Q3 2025 Jul 30, 2025 | $7.95B | $7.64B | -3.91% | $0.47 | $0.52 | +10.64% | — | — |
| Q2 2025 Jun 25, 2025 | — | $7.24B | — | — | -$0.22 | — | — | — |
| Q1 2025 Jan 30, 2025 | $7.06B | $7.28B | +3.02% | $0.63 | $0.42 | -33.33% | — | — |
| Q4 2024 Oct 31, 2024 | $7.45B | $7.91B | +6.12% | $0.39 | $0.44 | +12.82% | — | — |
| Q3 2024 Jul 31, 2024 | $6.98B | $7.52B | +7.69% | $0.37 | $0.56 | +51.35% | — | — |
| Q2 2024 May 9, 2024 | $6.06B | $6.93B | +14.28% | $0.00 | -$0.01 | -330.55% | — | — |
| Q1 2024 Feb 1, 2024 | $6.76B | $7.94B | +17.46% | $0.10 | $0.51 | +420.51% | — | — |
| Q4 2023 Oct 26, 2023 | $6.75B | $6.98B | +3.36% | $0.10 | $0.50 | +418.13% | — | — |
| Q3 2023 Jul 27, 2023 | $7.12B | $7.33B | +2.94% | $0.14 | $0.55 | +287.87% | — | — |
| Q2 2023 May 11, 2023 | $7.16B | $7.22B | +0.82% | $0.05 | $0.39 | +672.43% | — | — |
| Q1 2023 Feb 2, 2023 | $7.45B | $8.45B | +13.51% | $0.28 | $0.46 | +62.09% | — | — |
| Q2 2022 May 11, 2022 | $6.94B | $7.14B | +2.95% | $0.06 | $0.38 | +527.06% | — | — |
| Q1 2022 Feb 3, 2022 | $7.28B | $7.84B | +7.70% | $0.22 | $0.54 | +144.90% | — | — |
| Q2 2021 May 11, 2021 | — | $6.97B | — | — | $0.41 | — | — | — |
| Q4 2020 Oct 29, 2020 | $1.41T | $7.47B | -99.47% | $103.00 | $0.47 | -99.54% | — | — |
| Q3 2020 Jul 31, 2020 | $3.15T | $7.45B | -99.76% | $104.00 | $0.57 | -99.45% | — | — |
| Q2 2020 May 13, 2020 | — | $7.14B | — | — | $0.13 | — | — | — |
| Q1 2020 Feb 4, 2020 | $1.52T | $7.93B | -99.48% | $75.00 | $0.53 | -99.29% | — | — |